Harm R. Haak

Radboud University Nijmegen — Netherlands

Medicine · Health Sciences

49h-index10.9kcitations204works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adrenal and Paraganglionic Tumors(79), Cancer, Hypoxia, and Metabolism(50), Pituitary Gland Disorders and Treatments(46), Hormonal Regulation and Hypertension(43), Emergency and Acute Care Studies(26)

Publications202 total

Real-World Association of Lifestyle Reported Using Wearable Devices with Glycemic Excursions in People with Diabetes: The DiaGame Study
Diabetes Technology and Obesity Medicine·2026Open Access
Using Patient-Held Devices to Measure Variations in Resting Heart Rate and Step Count Prior to Presentation With an Acute Illness: International, Multicenter Flash Mob Feasibility Study
JMIR Cardio·2025Open Access
Evaluation of diagnostic measurements in patients with non-specific complaints: A secondary analysis after implementation of a care-pathway in the emergency department
PLoS ONE·2025Open Access
Evaluation of a care pathway for older adults presenting with nonspecific complaints at the emergency department: a before-and-after study
European Geriatric Medicine·2025· 4 citedOpen Access
Experienced cognitive load in the emergency department. A prospective study
PLoS ONE·2025· 3 citedOpen Access
The DiaGame Study: Multimodal Data Collection in Free-Living Conditions Using Consumer-Level Wearable Devices and Apps in People with Diabetes
2024· 2 citedOpen Access
Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424]
European Journal of Cancer·2024Open Access
Risk factors for hospitalisation in community-dwelling pre-frail and frail older people: results of a longitudinal study
BMC Geriatrics·2024· 1 citedOpen Access
Serious digital games for diabetes Mellitus: A scoping review of its current State, Accessibility, and functionality for patients and healthcare providers
Diabetes Research and Clinical Practice·2024· 3 citedOpen Access
Patients’ Perspectives and Feasibility of Home Monitoring in Acute Care: The AcuteCare@Home Flash Mob Study
Telemedicine Journal and e-Health·2024· 1 citedOpen Access
International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects
European Journal of Endocrinology·2024· 12 citedOpen Access
Response to Letter RE: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study
European Journal of Cancer·2024Open Access
38P Venous thromboembolism in patients with adrenocortical carcinoma: A multicentre retrospective study
ESMO Open·2024· 1 citedOpen Access
Can acutely ill patients predict their outcomes? A scoping review
Emergency Medicine Journal·2024· 2 citedOpen Access
Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study
European Journal of Cancer·2023· 13 citedOpen Access
630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study
Regular and Young Investigator Award Abstracts·2023Open Access
724O EO2401 (E) peptide immunotherapy + nivolumab (N) in adrenocortical carcinoma (ACC) and metastatic pheochromocytoma/paraganglioma (MPP): EOADR1-19/SPENCER
Annals of Oncology·2023· 2 citedOpen Access
Implementation of a care-pathway at the emergency department for older people presenting with nonspecific complaints; a protocol for a multicenter parallel cohort study
PLoS ONE·2023· 3 citedOpen Access
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
The Lancet Diabetes & Endocrinology·2023· 68 citedOpen Access
The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue
Biomedicines·2023· 2 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Martin Faßnacht(14), Massimo Terzolo(13), Lonneke V. van de Poll‐Franse(12), Matthias Kroiß(8), Thomas Kerkhofs(8), Éric Baudin(7), Bruno Allolio(6), Sophie Leboulleux(6), Marcus Quinkler(6), Felix Beuschlein(6), Cristina L. Ronchi(6), Richard A. Feelders(6), J.W.W. Coebergh(6), Patricia M. Stassen(6), Olga Husson(6), Alfredo Berruti(5), Timo Deutschbein(5), Myrthe P. P. van Herk‐Sukel(5), Willy‐Anne Nieuwlaat(5), Floortje Mols(5)